HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stacy L Moulder Selected Research

CP 609754 (CP 609,754)

11/2004A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stacy L Moulder Research Topics

Disease

43Neoplasms (Cancer)
05/2022 - 06/2002
39Breast Neoplasms (Breast Cancer)
05/2022 - 06/2002
22Triple Negative Breast Neoplasms
12/2022 - 11/2010
13Pathologic Complete Response
12/2022 - 12/2008
6Neoplasm Metastasis (Metastasis)
01/2020 - 07/2011
3Residual Neoplasm
05/2022 - 07/2016
3Disease Progression
12/2018 - 02/2010
3Ovarian Neoplasms (Ovarian Cancer)
05/2014 - 03/2011
2Insulin Resistance
01/2019 - 01/2013
2Overweight
01/2019 - 01/2013
2Diarrhea
07/2017 - 10/2008
2Circulating Neoplastic Cells
07/2014 - 08/2013
2Colorectal Neoplasms (Colorectal Cancer)
03/2014 - 03/2011
1Hyperglycemia
10/2021
1Carcinosarcoma
10/2021
1Necrosis
01/2021
1Neoplasm Micrometastasis
09/2020
1Brain Neoplasms (Brain Tumor)
01/2020
1Hyperinsulinism (Hyperinsulinemia)
01/2019
1Anemia
07/2017
1Exanthema (Rash)
07/2017
1Hypokalemia
07/2017

Drug/Important Bio-Agent (IBA)

13Hormones (Hormone)IBA
10/2021 - 01/2013
11Trastuzumab (Herceptin)FDA Link
11/2021 - 06/2002
8Pharmaceutical PreparationsIBA
10/2021 - 06/2008
7Biomarkers (Surrogate Marker)IBA
05/2022 - 07/2016
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 12/2008
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2019
4Metformin (Glucophage)FDA LinkGeneric
10/2021 - 01/2013
4Proteins (Proteins, Gene)FDA Link
10/2021 - 06/2002
4Estrogen ReceptorsIBA
10/2020 - 11/2010
4ErbB Receptors (EGF Receptor)IBA
10/2020 - 10/2008
4Lapatinib (GW572016)FDA Link
07/2019 - 09/2010
4Bevacizumab (Avastin)FDA Link
04/2017 - 09/2010
4human ERBB2 proteinIBA
01/2017 - 07/2014
3talazoparibIBA
05/2022 - 01/2020
3Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2022 - 05/2018
3pertuzumabIBA
11/2021 - 12/2018
3Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 02/2010
3Progesterone Receptors (Progesterone Receptor)IBA
10/2020 - 11/2010
3Letrozole (Femara)FDA LinkGeneric
07/2019 - 12/2017
3Estrogens (Estrogen)FDA Link
01/2019 - 05/2014
3EverolimusFDA Link
01/2019 - 05/2014
3MTOR InhibitorsIBA
01/2016 - 03/2012
3Tyrosine Kinase InhibitorsIBA
07/2015 - 06/2002
2Ado-Trastuzumab EmtansineIBA
11/2021 - 07/2019
2B7-H1 AntigenIBA
10/2021 - 01/2021
2Capecitabine (Xeloda)FDA Link
07/2019 - 06/2008
2Epidermal Growth Factor (EGF)IBA
01/2019 - 12/2018
2Histone Deacetylase InhibitorsIBA
01/2019 - 03/2014
2exemestane (Aromasin)FDA Link
01/2019 - 01/2013
2GemcitabineFDA Link
01/2018 - 08/2013
2taxaneIBA
01/2018 - 06/2008
2DNA (Deoxyribonucleic Acid)IBA
07/2015 - 03/2011
2Anastrozole (Arimidex)FDA LinkGeneric
05/2015 - 05/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 03/2014
2Monoclonal AntibodiesIBA
03/2014 - 06/2002
2Taxoids (Taxanes)IBA
12/2008 - 06/2008
2AnthracyclinesIBA
12/2008 - 06/2008
2Gefitinib (Iressa)FDA Link
10/2008 - 06/2003
1Complement System Proteins (Complement)IBA
01/2022
1ganitumabIBA
10/2021
1Hemoglobins (Hemoglobin)IBA
10/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1Histones (Histone)IBA
10/2021
1N-acetyltalosaminuronic acid (NAT)IBA
10/2021
1Folate Receptor 1IBA
01/2021
1mirvetuximab soravtansineIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2020
1AlpelisibIBA
01/2020
1olaparibIBA
01/2020
1telomerase RNA (bTR)IBA
07/2019
1thiamine triphosphorate (TTP)IBA
07/2019
1Androgen Receptors (Androgen Receptor)IBA
05/2019
1Phenobarbital (Luminal)FDA Link
05/2019
1ProteomeIBA
01/2019
1entinostat (MS 275)IBA
01/2019
1TOR Serine-Threonine KinasesIBA
01/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019
1Imatinib Mesylate (Gleevec)FDA Link
12/2018
1tipifarnib (R115777)IBA
01/2018
1VimentinIBA
01/2018
1Cyclin EIBA
12/2017
1Cytostatic AgentsIBA
12/2017
1Aromatase InhibitorsIBA
12/2017
1Transaminases (Aminotransferases)IBA
07/2017
1tucatinibIBA
07/2017
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2017
1liposomal doxorubicin (Doxil)FDA Link
04/2017
1Carboplatin (JM8)FDA LinkGeneric
07/2016
1neratinibIBA
07/2016
1veliparibIBA
07/2016

Therapy/Procedure

27Therapeutics
05/2022 - 11/2004
17Neoadjuvant Therapy
12/2022 - 01/2016
12Drug Therapy (Chemotherapy)
01/2019 - 05/2007
3Aftercare (After-Treatment)
01/2019 - 12/2015
1Surgical Instruments (Clip)
01/2022
1Lymph Node Excision (Lymph Node Dissection)
09/2020